Piramal, Anthem, or Cohance: Which CDMO stock has highest exposure to $20 billion ADC market?
- Posted on August 31, 2026
- By Financial Express
- 0 Views
- 1 min read
In brief
Generating AI summary…
Piramal, Anthem, or Cohance: Which CDMO stock has highest exposure to $20 billion ADC market?
India’s CDMO race is entering a specialised new phase as Piramal Pharma, Anthem Biosciences and Cohance Lifesciences build different routes into the fast-growing ADC manufacturing market.
